Detalles de la búsqueda
1.
Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study.
BMC Psychiatry
; 13: 253, 2013 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-24106804
2.
Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Study.
J Atten Disord
; 21(14): 1198-1207, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24464328
3.
Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study.
J Clin Psychiatry
; 74(7): 694-702, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23945447
Resultados
1 -
3
de 3
1
Próxima >
>>